SCHEMBL3282447

SCHEMBL3282447

COc1c(-c2ccc(O)c(O)c2)oc2ccccc2c1=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.71
HSD17B10 Q99714 4/20 0.71
MEN1 O00255 3/20 0.71
MAPT P10636 3/20 0.71
KMT2A Q03164 3/20 0.71
CYP3A4 P08684 3/20 0.71
RECQL P46063 2/20 0.71
TP53 P04637 2/20 0.71
CYP2C9 P11712 2/20 0.71
CYP2C19 P33261 2/20 0.71
CYP2D6 P10635 1/20 0.71
ST6GAL1 P15907 1/20 0.71
ALOX15 P16050 1/20 0.71
ALOX12 P18054 1/20 0.71
CDK2 P24941 1/20 0.71
MAPK1 P28482 1/20 0.71
ABCG2 Q9UNQ0 3/20 0.70
MMP1 P03956 1/20 0.69
POLB P06746 1/20 0.69
GAA P10253 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14259678 0.88 TUBB4A (0.74) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL29512814 0.87 KDM4E (0.73) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL34716 0.87 KDM4E (0.73) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL16882942 0.86 KDM4E (0.68) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL4165696 0.85 MAPT (0.64) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL5796864 0.85 ABCG2 (0.78) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL12266079 0.83 MAPT (0.59) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL13840378 0.83 ABCG2 (0.65) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL29149071 0.83 ABCG2 (0.63) KDM4EHSD17B10MEN1MAPTKMT2A
SCHEMBL4165699 0.83 POLH (0.71) KDM4EHSD17B10MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US claimed
US-7709223-B2 Method for detecting bacteria with chromogenic substrates for β-D-ribofuranosidase BURTON MICHAEL 2010-05-04 US disclosed
US-7531646-B2 β-D-ribosidase activity indicators with a chromogenic substrate BURTON MICHAEL 2009-05-12 US disclosed
US-7531646-B2 β-D-ribosidase activity indicators with a chromogenic substrate BURTON MICHAEL 2009-05-12 US disclosed
US-20080193959-A1 Enzyme Substrates BURTON MICHAEL 2008-08-14 US disclosed
US-7384763-B2 Method of detecting β-D-ribofuranosidase activity BURTON MICHAEL 2008-06-10 US disclosed
EP-1438423-B1 ENZYME ACTIVITY INDICATORS BURTON MICHAEL (GB) 2007-12-12 EP disclosed
EP-1438424-B1 ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY BURTON MICHAEL (GB) 2006-01-18 EP disclosed
US-20040259181-A1 detecting beta-D-ribofuranosidase activity using novel chromogenic beta-D-ribofuranoside substrates such as catechol-beta-D-ribofuranoside or 3',4'-dihydroxyflavone-4'-beta-D-dibofuranoside; kits BURTON MICHAEL (GB) 2004-12-23 US disclosed
US-20040235081-A1 Enzyme activity indicators BURTON MICHAEL (GB) 2004-11-25 US disclosed
EP-1438423-A1 ENZYME ACTIVITY INDICATORS Burton, Michael (GB) 2004-07-21 EP disclosed
EP-1438424-A2 ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY Burton, Michael (GB) 2004-07-21 EP disclosed
WO-2003035900-A1 ENZYME ACTIVITY INDICATORS BURTON MICHAEL (GB) 2003-05-01 WO disclosed
WO-2003035897-A2 ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY BURTON MICHAEL (GB) 2003-05-01 WO disclosed
US-20020147353-A1 Novel flavonoids VERENIGING CHRISTELIJK WETENSCHAPPELIJK ANDERWIJS (NL) 2002-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147353-A1 Novel flavonoids H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, ABCC8 KDM4E 3228/4885HSD17B10 892/4885MEN1 2151/4885
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 KDM4E 4144/4885HSD17B10 1555/4885MEN1 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.